The announcement comes after waves of criticism from Americans saying the drug, that's vital to many people with diabetes, should be more accessible.
If you're enjoying this article, you'll love my daily morning newsletter, How To LA. Every weekday, you'll get fresh, community-driven stories that catch you up with our independent local news.Big news this morning for anyone who relies on insulin: Drug manufacturer Eli Lilly announced that it's cutting the price by 70% on its"most commonly prescribed insulins.
The announcement comes after waves of criticism saying the drug, vital to many people with diabetes, should be more accessible. The price of insulin has increased 600% over the last 20 years and prompted California lawmakers to commit to producing the state's own brand of generic insulin to sell at below-market prices.According to the American Diabetes Association, 8 million people in the U.S. with diabetes rely on insulin — about 4 million of those in California.
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Drugmaker Eli Lilly says it's cutting insulin prices by 70%The drugmaker says it will cap monthly out-of-pocket insulin costs at $35 for people who are not covered by Medicare’s prescription drug program.
Read more »
Drugmaker Eli Lilly Plans to Cut Insulin Prices by 70%Eli Lilly, a U.S. drugmaker is capping the cost of Insulin at $35 per month for seniors with Medicare.
Read more »
Drugmaker Eli Lilly to slash insulin pricesBreaking: Eli Lilly will cut prices for some older insulins later this year and immediately expand a cap on costs insured patients pay when they fill prescriptions.
Read more »
Drugmaker Eli Lilly caps the cost of insulin at $35 a month, bringing relief for millionsThe move puts the drugmaker in line with a popular provision in the Inflation Reduction Act that capped the medication’s cost for seniors on Medicare.
Read more »
Under pressure, Eli Lilly cuts insulin prices 70%NEW: Eli Lilly is slashing the prices of its most-prescribed insulins amid pressure from consumers and the Biden administration. People with diabetes would see 70% reductions on its most common versions between now and the end of the year.
Read more »
Drugmaker to slash prices for some insulin medicationPeople with Type 1 diabetes must take insulin every day to survive.
Read more »